COVID-19 vaccines and Multiple sclerosis – update


Updates the February 11 slide deck. Includes data on the immune response to SARS-CoV-2, efficacy data for the Oxford-AstraZeneca vaccine, and updates the vaccine recommendations from the Canadian Network of MS Clinics.

13 slides

Recommend to a Colleague

Related Posts

Go back to home page